Does low DHEA-S indicate reduced adrenal androgen reserve?

Dehydroepiandrosterone sulfate (DHEA-S) is widely recognized in clinical endocrinology as the primary biomarker for assessing the functional capacity of the adrenal androgen-producing zone. Because DHEA-S has a long circulating half-life (10–20 hours) and minimal diurnal variation, a single serum measurement provides a stable reflection of the adrenal cortex's androgenic output.

Clinical and diagnostic evidence

Serum DHEA-S levels serve as a direct window into "adrenal androgen reserve," specifically the functional mass of the adrenal glands' zona reticularis.

• Adrenal dominance: In women, the adrenal glands are responsible for approximately 95% of circulating DHEA-S. While the ovaries produce significant amounts of testosterone and androstenedione, their contribution to DHEA-S is negligible (less than 10%), making DHEA-S a highly specific marker for adrenal rather than ovarian function.
• Thresholds for reduced reserve: In middle-aged populations, levels below the lowest age-adjusted quartiles—often defined clinically as <100 µg/dL (2.7 µmol/L)—are frequently used to indicate a significant depletion of adrenal androgen reserve. This may be seen in primary or secondary adrenal insufficiency or as a consequence of long-term glucocorticoid therapy.

Mechanistic explanations

The correlation between low DHEA-S and reduced reserve is driven by specific structural and enzymatic changes within the adrenal cortex.

• Zona reticularis involution: The decline in DHEA-S, known as adrenopause, is mechanically linked to the progressive thinning and cellular senescence of the zona reticularis. As functional cell mass decreases, the total enzymatic capacity to synthesize DHEA-S drops.
• Enzymatic shifts: Production depends on the high expression of sulfotransferase (SULT2A1) and cytochrome b5 (CYB5A). Low serum levels indicate a reduced expression of these enzymes or a metabolic shift where precursors are shunted away from the androgen pathway and toward glucocorticoid production.

Bottom line

Serum DHEA-S is a robust and scientifically validated indicator of adrenal androgen reserve. Because the adrenal cortex produces over 90% of circulating DHEA-S, lower levels are a direct reflection of diminished zona reticularis function or mass, whether due to natural aging (adrenopause), adrenal insufficiency, or pituitary suppression.